Rob Bickford

Rob Bickford has extensive work experience in finance and analysis roles. Rob currently holds the position of Senior Director of Finance at Third Harmonic Bio, a role they started in December 2022. Prior to this, they worked at Neoleukin Therapeutics as the Senior Director of Finance from February 2022 to December 2022, and as the Director of Finance from May 2021 to February 2022. Before joining Neoleukin Therapeutics, Rob worked at DaVita Kidney Care, where they held multiple positions including Director of Finance from December 2019 to May 2021, Senior Manager of Finance from December 2018 to December 2019, Manager of Finance from February 2017 to December 2018, and Senior Analyst of Finance from March 2015 to February 2017. Rob began their career as a Business & Planning Analyst at Boeing from January 2014 to March 2015. Rob also has experience as a Graduate Fellow at Pacific Lutheran University from November 2012 to May 2013.

Rob Bickford holds a Bachelor of Business Administration (BBA) degree in Finance from Pacific Lutheran University - School of Business, which they earned between 2008 and 2012. Rob later pursued a Master of Science in Finance from the same institution between 2012 and 2013. Additionally, Rob has passed all three exams of the CFA Institute and may be awarded the charter upon completion of required work experience. Prior to their university education, they attended Shorewood High School.